Yes, AIT offers specialty or niche products within its pharmaceutical range to address specific medical conditions or patient populations. These products may include:
-
- Orphan Drugs: Medications developed to treat rare diseases or conditions that affect a small percentage of the population.
- Biologics: Complex molecules derived from living organisms, such as proteins, antibodies, or nucleic acids, used for targeted therapy in conditions like cancer, autoimmune disorders, or genetic diseases.
- Biosimilars: Biological products that are highly similar to existing biologic medicines, providing affordable alternatives for patients.
- Hormonal Therapies: Pharmaceuticals targeting hormonal imbalances or conditions related to the endocrine system, including contraceptives, hormone replacement therapy, or treatments for reproductive disorders.
- Immunotherapies: Innovative treatments that harness the body’s immune system to fight diseases such as cancer, autoimmune disorders, or infectious diseases.
- Personalized Medicines: Tailored treatments based on genetic, biomarker, or other patient-specific characteristics to optimize therapeutic outcomes and minimize adverse effects.
- Advanced Drug Delivery Systems: Novel formulations or technologies that enhance drug absorption, distribution, metabolism, and excretion, improving drug efficacy and patient adherence.
- Compounded Medications: Customized formulations prepared by pharmacists to meet specific patient needs, such as individualized dosages, flavors, or dosage forms not commercially available.
- Nutraceuticals: Pharmaceuticals derived from food sources or containing dietary ingredients with purported health benefits beyond basic nutrition, targeting areas like immune support, cognitive health, or joint mobility.
- Veterinary Pharmaceuticals: Medications specifically formulated for use in animals, including companion pets, livestock, or exotic species, addressing various veterinary healthcare needs.
These specialty or niche products demonstrate AIT’s commitment to innovation and addressing unmet medical needs across diverse therapeutic areas and patient populations.
